NCT00058006View on ClinicalTrials.gov

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Head and Neck CancerLung Cancer
Interventions
DRUG

celecoxib

PROCEDURE

adjuvant therapy

Trial Locations (4)

60612

Rush Cancer Institute at Rush University Medical Center, Chicago

60611-3013

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

60637-1470

University of Chicago Cancer Research Center, Chicago

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00058006 - Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter